Login to Your Account

CROI 2018

When used early, Abs may do what ART cannot

By Anette Breindl
Senior Science Editor

Thursday, March 8, 2018

BOSTON – Long-term control of HIV without the need for ongoing antiretroviral therapy (ART), even though it is not a cure, would be a major milestone for HIV treatment. At the Conference on Retroviruses and Opportunistic Infections (CROI) this week, researchers suggested that it may be possible to find treatments that induce such long-term control, through a combination of ART and broadly neutralizing antibodies (bNAbs).

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription